Alpha Tau Medical Ltd DRTS 深 沪
等待开盘 08-17 09:30:00 美东时间
14.25
-0.250
-1.72%
华盛通- 最 高14.52
- 今 开14.41
- 成交量 31.48万股
- 最 低 14.14
- 昨 收 14.50
- 总市值 12.54亿
- 52周最高 14.75
- 市盈率 静 --
- 换手率 0.36%
- 52周最低 3.09
- 委 比 65.34%
- 总股本 8800.97万
- 历史最高 20.65
- 量 比 0.50
- 振 幅 2.62%
- 历史最低 1.75
- 每 手 1
- 风险率 3.07%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅207.38%！Truist Securities上调AbCellera Biologics目标价至30美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持AbCellera Biologics"买入"评级，目标价从12美元升至30美元；Stifel：维持Proficient Auto Logistics"买入"评级，目标价从9美元升至12美元
08-12 08:45
HC Wainwright & Co. Maintains Buy on Alpha Tau Medical, Raises Price Target to $16
HC Wainwright & Co. analyst Yi Chen maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and raises the price target from $15 to $16.
08-11 22:58
Alpha Tau Medical Q2 EPS $(0.50) Misses $(0.14) Estimate
Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.14) by 257.14 percent. This is a 284.62 percent decrease over losses of $(0.13) per share from the same period last year.
08-11 04:39
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update
Alpha Tau Medical Ltd. reported strong progress in Q2 2026, including 100% local disease control in recurrent glioblastoma trials, strategic collaboration with Tolmar for prostate cancer, and successful patient enrollment in key studies. The company also presented promising data in pancreatic and head & neck cancers, with a cash balance of $104.8 million supporting its growth.
08-10 20:01
美股大行评级 | 阿斯麦、贝莱德、纽约梅隆银行、信达思、JB亨特运输服务、美国制商银行、PNC金融服务集团等获多家大行集体上调目标价
今日重点评级关注：瑞杰金融：维持Electrovaya"强力买入"评级，目标价从14美元升至22美元；BTIG：维持vTv Therapeutics"买入"评级，目标价从49美元升至57美元
07-17 11:35
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $15 price target.
07-16 22:14
Alpha Tau Medical Announces Success Treatment With Alpha DaRT Of First Glioblastoma Patient In Israel
Alpha Tau Medical Ltd. (NASDAQ:DRTS, DRTSW)) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced the successful treatment with Alpha DaRT of the first glioblastoma patient in Israel, and the first ever outside of the United States, performed at ...
06-23 20:33
美股大行评级 | 绩后暴跌，博通仍获11家大行上调目标价；CrowdStrike获21家大行集体上调目标价；Netskope、Veeva Systems惨遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Vivos Therapeutics"买入"评级，目标价从3美元升至3.1美元；富国银行：维持Veeva Systems"超配"评级，目标价从317美元升至320美元
06-05 11:33
美股牛股 | 黄仁勋概念股又+1！凭AI电源技术切入“达链”，纳微半导体暴涨超19%；MiniMed Group大涨近16%
黄仁勋概念股又+1！凭AI电源技术切入“达链”，纳微半导体暴涨超19%；季度销售额超预期！MiniMed Group大涨近16%>>
06-04 18:56
